Healthcare -
Biotechnology - NASDAQ - DK
$ 156.58
2.25 %
$ 9.37 B
Market Cap
-22.86
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ascendis Pharma A/S
| Net Income | -378 M |
| Depreciation & Amortization | 17.7 M |
| Capital Expenditures | -1.43 M |
| Stock-Based Compensation | 95.5 M |
| Change in Working Capital | -107 M |
| Others | 159 M |
| Free Cash Flow | -308 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (378.1) | (481.4) | (583.2) | (383.6) | (419.0) | (218.0) | (130.1) | (123.9) | (68.5) | (32.9) | (9.7) | 4.1 | 1.2 |
| Depreciation & Amortization | 17.7 | 18.9 | 18.0 | 15.4 | 9.4 | 6.7 | 0.9 | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | 0.4 |
| Deferred Income Tax | 4.8 | 7.3 | 5.4 | (0.4) | (0.2) | (0.2) | (0.4) | (0.5) | (0.2) | (0.7) | (0.7) | 0.6 | 35 K |
| Stock Based Compensation | 95.5 | 66.7 | 64.2 | 66.8 | 53.2 | 37.5 | 19.7 | 9.7 | 7.3 | 1.7 | 1.3 | 0.7 | 0.1 |
| Other Operating Activities | 61.0 | 21.0 | 18.6 | (67.0) | 86.0 | (5.9) | (30.5) | 13.8 | (3.5) | (7.5) | (2.4) | 4 K | 35 K |
| Change in Working Capital | (107.2) | (99.8) | (18.6) | (48.9) | (1.0) | 4.1 | 1.7 | 5.0 | 4.1 | (4.7) | (7.4) | 0.5 | (2.5) |
| Cash From Operations | (306.2) | (467.4) | (495.7) | (417.6) | (271.5) | (175.9) | (138.8) | (95.1) | (60.2) | (43.5) | (18.4) | 6.3 | (0.7) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (1.4) | (2.4) | (14.5) | (24.2) | (21.6) | (5.2) | (2.6) | (0.9) | (0.7) | (1.0) | (0.4) | (1.2) | (0.3) |
| Other Items | 8.3 | 288.9 | 76.2 | (86.3) | (269.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 6.9 | 286.5 | 61.7 | (110.6) | (291.2) | (5.2) | (2.6) | (0.9) | (0.7) | (1.0) | (0.4) | (1.2) | (0.3) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | (1.8) | (105.3) | (21.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 122.8 | 125.8 | 496.9 | (6.4) | (4.8) | (4.0) | 0 | 0 | 0 | 0 | 0 | (0.2) | (0.2) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 11.2 | 8.5 | 5.2 | 11.5 | 26.9 | 17.4 | (13.1) | (8.4) | (8.5) | (8.4) | (0.2) | 0 | 0 |
| Cash From Financing Activities | 443.9 | 134.3 | 396.8 | 351.4 | 602.6 | 493.6 | 203.3 | 124.7 | 117.5 | 105.7 | 47.9 | (0.2) | (0.2) |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 167.4 | (52.6) | (1.5) | (138.2) | (13.6) | 320.2 | 82.5 | 15.0 | 60.7 | 69.5 | 30.7 | 4.9 | (1.1) |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (307.6) | (469.8) | (510.2) | (441.9) | (293.1) | (181.1) | (141.4) | (96.0) | (60.9) | (44.5) | (18.8) | 5.1 | (0.9) |